title: PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels.
authors.forename: René
authors.initials: R
authors.lastname: Mulder
authors.forename: Min Ki
authors.initials: MK
authors.lastname: ten Kate
authors.forename: Hanneke C
authors.initials: HC
authors.lastname: Kluin-Nelemans
authors.forename: André B
authors.initials: AB
authors.lastname: Mulder
mesh_terms: D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000378:metabolism* / Q000473:pathology; D001798:Blood Proteins / Q000235:genetics / Q000378:metabolism*; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D005190:Family; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008074:Lipoproteins / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D011110:Polymorphism, Genetic; D017293:Protein S; D012306:Risk; D054556:Venous Thromboembolism / Q000097:blood* / Q000175:diagnosis / Q000235:genetics*; D055815:Young Adult
chemical_list: D001798:Blood Proteins; D008074:Lipoproteins; C523390:PROS1 protein, human; D017293:Protein S; C051928:lipoprotein-associated coagulation inhibitor